Chlamydia pneumoniae infections and development of lung cancer: systematic review
- PMID: 35317845
- PMCID: PMC8941765
- DOI: 10.1186/s13027-022-00425-3
Chlamydia pneumoniae infections and development of lung cancer: systematic review
Abstract
Background: Chlamydia pneumoniae is an obligate intracellular pathogen and is a common cause of human respiratory diseases, including pneumonia. It has been already known to have a causal relationship with some chronic diseases such as chronic obstructive pulmonary disease, asthma, and atherosclerotic cardiovascular diseases. In this review, we aim to find out the association between C. pneumoniae infection and lung cancer.
Methods: This is a systematic review on C. pneumoniae infection and the development of lung cancer, based on published articles consolidated from PubMed and Google Scholar on the topic.
Results: Out of 46 articles, 27 were selected and screened through the process. Twenty-four articles positively supported the hypothesis with one animal model, while 3 of them were negatively supportive. Several proposed mechanisms explain the pathogenesis with some knowledge gaps.
Conclusion: Although some studies showed an association between C. pneumoniae infection and lung cancer, whether the C. pneumoniae infection is an individual risk factor for lung cancer is still debatable. And it needs further experimental studies on both humans and animals with large observational studies to better understand the association between C. pneumoniae infection and lung cancer.
Keywords: Chlamydia pneumoniae; Lung cancer; Risk factor; Serology.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Chlamydia pneumoniae as a respiratory pathogen.Front Biosci. 2002 Mar 1;7:e66-76. doi: 10.2741/hahn. Front Biosci. 2002. PMID: 11861211 Review.
-
Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis.Eur J Cancer. 2011 Mar;47(5):742-7. doi: 10.1016/j.ejca.2010.11.003. Epub 2010 Dec 29. Eur J Cancer. 2011. PMID: 21194924 Review.
-
Chlamydia pneumoniae and lung cancer: epidemiologic evidence.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):773-8. doi: 10.1158/1055-9965.EPI-04-0599. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824142 Review.
-
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?Ann Allergy Asthma Immunol. 1999 Oct;83(4):271-88, 291; quiz 291-2. doi: 10.1016/S1081-1206(10)62666-X. Ann Allergy Asthma Immunol. 1999. PMID: 10541419 Review.
-
Severity of allergic airway disease due to house dust mite allergen is not increased after clinical recovery of lung infection with Chlamydia pneumoniae in mice.Infect Immun. 2013 Sep;81(9):3366-74. doi: 10.1128/IAI.00334-13. Epub 2013 Jul 1. Infect Immun. 2013. PMID: 23817611 Free PMC article.
Cited by
-
Insights into the Two Most Common Cancers of Primitive Gut-Derived Structures and Their Microbial Connections.Medicina (Kaunas). 2024 Sep 18;60(9):1515. doi: 10.3390/medicina60091515. Medicina (Kaunas). 2024. PMID: 39336556 Free PMC article. Review.
-
Alternative strategies for Chlamydia treatment: Promising non-antibiotic approaches.Front Microbiol. 2022 Nov 23;13:987662. doi: 10.3389/fmicb.2022.987662. eCollection 2022. Front Microbiol. 2022. PMID: 36504792 Free PMC article. Review.
-
Insights into Chlamydia Development and Host Cells Response.Microorganisms. 2024 Jun 26;12(7):1302. doi: 10.3390/microorganisms12071302. Microorganisms. 2024. PMID: 39065071 Free PMC article. Review.
-
Microbial dysbiosis with tryptophan metabolites alteration in lower respiratory tract is associated with clinical responses to anti-PD-1 immunotherapy in advanced non-small cell lung cancer.Cancer Immunol Immunother. 2025 Mar 8;74(4):140. doi: 10.1007/s00262-025-03996-3. Cancer Immunol Immunother. 2025. PMID: 40056186 Free PMC article.
-
The association between Chlamydia pneumoniae infection and prognosis in lung cancer patients: a prospective study.BMC Infect Dis. 2025 Jan 25;25(1):119. doi: 10.1186/s12879-025-10515-3. BMC Infect Dis. 2025. PMID: 39863864 Free PMC article.
References
-
- Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR) Clinical Microbiology Reviews. American Society for Microbiology; 1995 [cited 2021 Jun 21]. p. 451–61. https://journals.asm.org/journal/cmr - PMC - PubMed
-
- E. P. Is Chlamydophila pneumoniae an etiological agent of non-infectious diseases? Vol. 44, Postepy Mikrobiologii. 2005.
-
- Chlamydia pneumoniae Infection and Inflammatory Diseases [Internet]. [cited 2021 Jun 21]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345537/
-
- Shen M, Cai L, Jiang K, Xu W, Chen Y, Xu Z. The therapeutic role of inhibition of miR-328 on pulmonary carcinoma induced by chlamydia pneumoniae through targeting histone H2AX. Cancer Biomarkers. 2019; - PubMed
Publication types
LinkOut - more resources
Full Text Sources